The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

NCT05630651 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
6
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China